Abstract 7864: Signal-Averaged ECG Abnormalities in Hypertrophic Cardiomyopathy: Associations with Disease Severity, Arrhythmia, and Sleep Apnea
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.7864 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Shahid Karim und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
The signal-averaged ECG (SA-ECG) detects ventricular late potentials (VLPs), a potential marker for arrhythmogenic substrate. Obstructive sleep apnea (OSA), highly prevalent in HCM, may also contribute to this substrate, but the interplay between SA-ECG, OSA, and HCM severity is poorly understood. This study aimed to determine these relationships and evaluate the prognostic value of SA-ECG abnormalities for incident atrial fibrillation (AF) and major adverse cardiovascular events (MACE).
Methods
In this prospective study, 91 consecutive patients with HCM underwent polysomnography to diagnose OSA, and high-resolution SA-ECG to detect VLPs. An abnormal SA-ECG was defined as meeting ≥2 of 3 criteria. Multivariable regression was used to identify predictors of SA-ECG abnormalities and Cox proportional-hazards models were used to assess outcomes (incident AF and MACE; a composite of death, stroke, heart failure exacerbation requiring hospital admission, and sustained ventricular tachyarrhythmia) over a median 5.8-year follow-up, adjusting for age and BMI.
Results
OSA was present in 65% of patients. In unadjusted analyses, OSA was associated with a higher prevalence of individual SA-ECG abnormalities and was independently associated with adverse structural remodeling. After multivariable adjustment, the direct association between OSA and a globally abnormal SA-ECG was attenuated, while markers of disease severity (like prior myectomy and left ventricular mass index) remained the strongest predictors. This suggests the influence of OSA on SA-ECG is likely mediated by the structural remodeling it induces. An abnormal SA-ECG was significantly associated with incident AF (log-rank p=0.018 - Figure 1) and with MACE in univariable analysis (log-rank p=0.038 - Figure 2), although this association did not persist after multivariable adjustment (HR 1.93, 95% CI 0.93-4.01, p=0.079).
Conclusions
SA-ECG abnormalities in HCM represent an electrical marker of advanced structural myopathy. The association between OSA and SA-ECG abnormalities appears to be mediated by the structural cardiac changes induced by OSA. While its independent prognostic value for MACE was not evident in this study, the SA-ECG may be a useful, non-invasive tool to assess arrhythmogenic substrate in HCM.
Zitieren
APA
Karim, S., Khan, S., Gajjar, A., HUSSAIN, H., Makarla, V. A., Barakat, M., Chahal, C. A. A. A., & Somers, V. K. (2026). Abstract 7864: Signal-Averaged ECG Abnormalities in Hypertrophic Cardiomyopathy: Associations with Disease Severity, Arrhythmia, and Sleep Apnea. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.7864
Vancouver
Karim S, Khan S, Gajjar A, HUSSAIN H, Makarla VA, Barakat M, et al. Abstract 7864: Signal-Averaged ECG Abnormalities in Hypertrophic Cardiomyopathy: Associations with Disease Severity, Arrhythmia, and Sleep Apnea. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.7864
BibTeX
@article{Karim2026,
author = {Karim, Shahid and Khan, Saifullah and Gajjar, Amani and HUSSAIN, Haris and Makarla, Venkata Akhil and Barakat, Mohammad and Chahal, Choudhary Anwar A. A and Somers, Virend K},
title = {Abstract 7864: Signal-Averaged ECG Abnormalities in Hypertrophic Cardiomyopathy: Associations with Disease Severity, Arrhythmia, and Sleep Apnea},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.7864}
}
EUVIMED